Literature DB >> 28923390

TNF-α and IL-6 inhibitors: Conjugates of N-substituted indole and aminophenylmorpholin-3-one as anti-inflammatory agents.

Palwinder Singh1, Sukhmeet Kaur2, Anuradha Sharma3, Gurcharan Kaur3, Rajbir Bhatti4.   

Abstract

The conjugates obtained by the combination of indole and aminophenyl morpholinone were screened for TNF-α and IL-6 inhibition in microglial cells. Compound 4 was found to be the most potent anti-inflammatory agent as it reduced LPS induced level of inflammatory cytokines TNF-α and IL-6 by 71% and 53%, respectively. A significant decrease in NO and MMPs release from BV2 cells in culture pretreated with this compound as well as inhibition of nuclear translocation of NF-κB and AP-1 was observed. 75% inhibition of acetic acid induced algesia in swiss albino mice was noticed in the presence of compound 4. Experimental data and molecular docking studies indicate that the compounds are targeting TNF-α, iNOS and IL-6.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory activity; Indole; Interleukin-6; Lipopolysaccharide; Nitric oxide; Tumor necrosis factor-α

Mesh:

Substances:

Year:  2017        PMID: 28923390     DOI: 10.1016/j.ejmech.2017.09.003

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Anti-inflammatory activity of novel thiosemicarbazone compounds indole-based as COX inhibitors.

Authors:  Íris T T Jacob; Fabiana O S Gomes; Mirelly D S de Miranda; Sinara M V de Almeida; Iranildo J da Cruz-Filho; Christina A Peixoto; Teresinha G da Silva; Diogo R M Moreira; Cristiane M L de Melo; Jamerson F de Oliveira; Maria C A de Lima
Journal:  Pharmacol Rep       Date:  2021-02-15       Impact factor: 3.024

2.  Synthesis and Biological Evaluation of Thalidomide Derivatives as Potential Anti-Psoriasis Agents.

Authors:  Kai-Wei Tang; Zih-Chan Lin; Yeh-Long Chen; Cherng-Chyi Tzeng; Jia-You Fang; Chih-Hua Tseng
Journal:  Int J Mol Sci       Date:  2018-10-07       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.